Clinical trial
Predictive Value of Glycocalyx Biomarkers in Mechanical Ventilation of Patients With ARDS for Clinical Prognosis and Long-term Pulmonary Fibrosis
NCT03854565 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Value of Glycocalyx Biomarkers in Mechanical Ventilation of Patients With ARDS for Clinical Prognosis and Long-term Pulmonary Fibrosis
- Lead sponsor
- Southeast University, China
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2019
- Completion date
- December 31, 2019
- Enrollment
- 336 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ards, human, endothelial dysfunction, mechanical ventilation pressure high